Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients.
Related Research units
Abstract
Minority drug-resistant HIV-1 variants, undetected by conventional genotyping, may impair the outcome of antiretroviral therapy (ART). Thus, we retrospectively analyzed the prevalence of minority drug-resistant HIV-1 variants before ART in chronically HIV-1 infected patients initiating first-line therapy and assessed the impact on clinical outcome in the prospective German Truvada cohort.
Bibliographical data
| Original language | German |
|---|---|
| Article number | 2 |
| ISSN | 1386-6532 |
| Publication status | Published - 2011 |
| pubmed | 21056001 |
|---|
